Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUSNYSE:ARDTNASDAQ:INNVNASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$115.12-0.4%$110.24$88.96▼$136.72$2.12B0.81166,556 shs285,580 shsARDTArdent Health$13.69+2.9%$13.75$11.31▼$20.72$1.96BN/A384,125 shs827,810 shsINNVInnovAge$3.92-0.5%$3.68$2.60▼$6.69$529.25M0.5550,852 shs111,014 shsPGNYProgyny$21.91+2.1%$21.84$13.39▼$30.42$1.88B1.321.71 million shs2.65 million shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-0.45%+1.17%+1.63%+18.31%-3.68%ARDTArdent Health+2.97%+5.11%-7.69%+3.91%+1,368,999,900.00%INNVInnovAge-0.51%+0.77%-3.21%+30.67%-18.16%PGNYProgyny+2.10%+4.43%+3.11%+0.05%-20.44%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.7335 of 5 stars2.65.00.05.01.82.52.5ARDTArdent Health3.2131 of 5 stars3.50.00.00.01.70.03.1INNVInnovAge2.0515 of 5 stars2.82.00.00.03.41.70.6PGNYProgyny1.1989 of 5 stars1.22.00.00.02.62.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5723.85% UpsideARDTArdent Health 3.00Buy$20.6750.96% UpsideINNVInnovAge 1.50Reduce$5.0027.55% UpsidePGNYProgyny 2.42Hold$23.457.05% UpsideCurrent Analyst Ratings BreakdownLatest INNV, ARDT, ADUS, and PGNY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/20/2025ARDTArdent HealthStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.005/15/2025ARDTArdent HealthRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/9/2025ARDTArdent HealthGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$16.00 ➝ $18.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.004/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/10/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/9/2025ARDTArdent HealthGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$16.004/9/2025ARDTArdent HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$19.00 ➝ $18.00(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.83$5.39 per share21.36$53.52 per share2.15ARDTArdent Health$5.97B0.33$2.54 per share5.39$10.66 per share1.28INNVInnovAge$763.85M0.69N/AN/A$2.04 per share1.92PGNYProgyny$1.17B1.61$0.35 per share63.49$4.96 per share4.42Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4325.9921.481.636.52%9.23%6.96%8/4/2025 (Estimated)ARDTArdent Health$210.34M$1.638.406.981.243.73%16.07%4.69%8/13/2025 (Estimated)INNVInnovAge-$21.34M-$0.23N/A65.33N/A-3.75%-11.91%-5.85%9/9/2025 (Estimated)PGNYProgyny$54.34M$0.5738.4433.712.304.33%10.90%7.20%8/5/2025 (Estimated)Latest INNV, ARDT, ADUS, and PGNY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/6/2025Q1 2025ARDTArdent Health$0.21$0.29+$0.08$0.29$1.50 billion$1.50 billion5/6/2025Q3 2025INNVInnovAge-$0.02-$0.08-$0.06-$0.08$214.09 million$218.14 million5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AARDTArdent HealthN/AN/AN/AN/AN/AINNVInnovAgeN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74ARDTArdent Health0.702.121.98INNVInnovAge0.040.780.78PGNYProgynyN/A2.392.39Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%ARDTArdent HealthN/AINNVInnovAge12.26%PGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%ARDTArdent Health1.70%INNVInnovAge1.40%PGNYProgyny9.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableARDTArdent Health24,900143.04 million140.61 millionOptionableINNVInnovAge2,350135.01 million133.12 millionOptionablePGNYProgyny31085.72 million77.66 millionOptionableINNV, ARDT, ADUS, and PGNY HeadlinesRecent News About These CompaniesProgyny, Inc. (NASDAQ:PGNY) Receives Average Rating of "Hold" from AnalystsJune 28 at 2:35 AM | marketbeat.comProgyny Expands Women's Health Offerings with New Pelvic Floor Therapy Services - NasdaqJune 26 at 7:11 AM | nasdaq.comProgyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s HealthJune 24, 2025 | finance.yahoo.comHinge Health joins Progyny for pelvic floor therapyJune 24, 2025 | msn.comProgyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's HealthJune 24, 2025 | globenewswire.comProgyny Earns Relative Strength Rating UpgradeJune 23, 2025 | msn.comProgyny (PGNY) Soared on Expanding Client Base and Improving Utilization TrendsJune 18, 2025 | msn.comFort Washington Investment Advisors Inc. OH Reduces Stake in Progyny, Inc. (NASDAQ:PGNY)June 13, 2025 | marketbeat.comGAMMA Investing LLC Acquires 118,556 Shares of Progyny, Inc. (NASDAQ:PGNY)June 13, 2025 | marketbeat.comCheryl Scott Sells 2,675 Shares of Progyny, Inc. (NASDAQ:PGNY) StockJune 12, 2025 | marketbeat.comProgyny Stock Trades Higher On Collaboration With Amazon’s Health Benefits Connector: Retail’s Yet To Be ImpressedJune 10, 2025 | msn.comProgyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building SolutionJune 10, 2025 | finance.yahoo.comProgyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building SolutionJune 10, 2025 | globenewswire.comHere’s Why Progyny (PGNY) Rebounded in Q1June 9, 2025 | msn.comOlstein Capital Management L.P. Buys New Shares in Progyny, Inc. (NASDAQ:PGNY)June 9, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Acquired by NBC Securities Inc.June 6, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Position in Progyny, Inc. (NASDAQ:PGNY)June 5, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Stock Position Lessened by Wellington Management Group LLPJune 4, 2025 | marketbeat.comLeibman Financial Services Inc. Sells 18,076 Shares of Progyny, Inc. (NASDAQ:PGNY)June 3, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation of "Hold" by BrokeragesJune 3, 2025 | marketbeat.comMackenzie Financial Corp Boosts Stock Position in Progyny, Inc. (NASDAQ:PGNY)June 1, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINNV, ARDT, ADUS, and PGNY Company DescriptionsAddus HomeCare NASDAQ:ADUS$115.12 -0.52 (-0.45%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$115.12 -0.01 (0.00%) As of 06/27/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Ardent Health NYSE:ARDT$13.69 +0.38 (+2.85%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$13.68 -0.01 (-0.07%) As of 06/27/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.InnovAge NASDAQ:INNV$3.92 -0.02 (-0.51%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$3.92 0.00 (0.00%) As of 06/27/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Progyny NASDAQ:PGNY$21.91 +0.45 (+2.10%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$21.91 0.00 (0.00%) As of 06/27/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Broadcom’s Big VMware Update: A Threat to Public Cloud Giants? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.